209 related articles for article (PubMed ID: 27054693)
21. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
[TBL] [Abstract][Full Text] [Related]
22. Weekly enhanced T1-weighted MRI with Gadobutrol injections in MS patients: Is there a signal intensity increase in the dentate nucleus and the globus pallidus?
Jaulent P; Hannoun S; Kocevar G; Rollot F; Durand-Dubief F; Vukusic S; Brisset JC; Sappey-Marinier D; Cotton F
Eur J Radiol; 2018 Aug; 105():204-208. PubMed ID: 30017281
[TBL] [Abstract][Full Text] [Related]
23. Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study.
Forslin Y; Shams S; Hashim F; Aspelin P; Bergendal G; Martola J; Fredrikson S; Kristoffersen-Wiberg M; Granberg T
AJNR Am J Neuroradiol; 2017 Jul; 38(7):1311-1316. PubMed ID: 28495943
[TBL] [Abstract][Full Text] [Related]
24. Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder.
Masuda H; Hirano S; Takahashi N; Hatsugano E; Uzawa A; Uchida T; Ohtani R; Kuwabara S; Mori M
PLoS One; 2017; 12(8):e0184012. PubMed ID: 28846745
[TBL] [Abstract][Full Text] [Related]
25. Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
Ota M; Sato N; Okamoto T; Noda T; Araki M; Yamamura T; Kunugi H
Mult Scler Relat Disord; 2015 Nov; 4(6):515-20. PubMed ID: 26590657
[TBL] [Abstract][Full Text] [Related]
26. Gray Matter Nucleus Hyperintensity After Monthly Triple-Dose Gadopentetate Dimeglumine With Long-term Magnetic Resonance Imaging.
DeBevits JJ; Munbodh R; Bageac D; Wu R; DiCamillo PA; Hu C; Wang L; Naismith RT; Karimeddini D; Dhib-Jalbut S; Redko S; Cook SD; Cadavid D; Wolansky L
Invest Radiol; 2020 Oct; 55(10):629-635. PubMed ID: 32898355
[TBL] [Abstract][Full Text] [Related]
27. Radiomics in multiple sclerosis and neuromyelitis optica spectrum disorder.
Liu Y; Dong D; Zhang L; Zang Y; Duan Y; Qiu X; Huang J; Dong H; Barkhof F; Hu C; Fang M; Tian J; Li K
Eur Radiol; 2019 Sep; 29(9):4670-4677. PubMed ID: 30770971
[TBL] [Abstract][Full Text] [Related]
28. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.
Kanda T; Osawa M; Oba H; Toyoda K; Kotoku J; Haruyama T; Takeshita K; Furui S
Radiology; 2015 Jun; 275(3):803-9. PubMed ID: 25633504
[TBL] [Abstract][Full Text] [Related]
29. Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder.
Kim SH; Kwak K; Hyun JW; Jeong IH; Jo HJ; Joung A; Kim JH; Lee SH; Yun S; Joo J; Lee JM; Kim HJ
Eur J Neurol; 2016 Jul; 23(7):1165-73. PubMed ID: 27108769
[TBL] [Abstract][Full Text] [Related]
30. In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents.
Tedeschi E; Palma G; Canna A; Cocozza S; Russo C; Borrelli P; Lanzillo R; Angelini V; Postiglione E; Morra VB; Salvatore M; Brunetti A; Quarantelli M
Eur Radiol; 2016 Dec; 26(12):4577-4584. PubMed ID: 26905870
[TBL] [Abstract][Full Text] [Related]
31. Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children.
Rossi Espagnet MC; Bernardi B; Pasquini L; Figà-Talamanca L; Tomà P; Napolitano A
Pediatr Radiol; 2017 Sep; 47(10):1345-1352. PubMed ID: 28526896
[TBL] [Abstract][Full Text] [Related]
32. Choroid plexus changes on magnetic resonance imaging in multiple sclerosis and neuromyelitis optica spectrum disorder.
Kim H; Lim YM; Kim G; Lee EJ; Lee JH; Kim HW; Kim KK
J Neurol Sci; 2020 Aug; 415():116904. PubMed ID: 32446012
[TBL] [Abstract][Full Text] [Related]
33. Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent.
Barisano G; Bigjahan B; Metting S; Cen S; Amezcua L; Lerner A; Toga AW; Law M
AJNR Am J Neuroradiol; 2019 Aug; 40(8):1274-1281. PubMed ID: 31345942
[TBL] [Abstract][Full Text] [Related]
34. Absence of dentate nucleus resting-state functional connectivity changes in nonneurological patients with gadolinium-related hyperintensity on T
Mallio CA; Piervincenzi C; Gianolio E; Cirimele V; Papparella LG; Marano M; Quintiliani L; Aime S; Carducci F; Parizel PM; Quattrocchi CC
J Magn Reson Imaging; 2019 Aug; 50(2):445-455. PubMed ID: 30681245
[TBL] [Abstract][Full Text] [Related]
35. Gadolinium deposition in the paediatric brain: T1-weighted hyperintensity within the dentate nucleus following repeated gadolinium-based contrast agent administration.
Young JR; Orosz I; Franke MA; Kim HJ; Woodworth D; Ellingson BM; Salamon N; Pope WB
Clin Radiol; 2018 Mar; 73(3):290-295. PubMed ID: 29208312
[TBL] [Abstract][Full Text] [Related]
36. Callosal lesions on magnetic resonance imaging with multiple sclerosis, neuromyelitis optica spectrum disorder and acute disseminated encephalomyelitis.
Cai MT; Zhang YX; Zheng Y; Fang W; Ding MP
Mult Scler Relat Disord; 2019 Jul; 32():41-45. PubMed ID: 31030018
[TBL] [Abstract][Full Text] [Related]
37. Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid.
Long Y; Chen M; Zhang B; Gao C; Zheng Y; Xie L; Gao Q; Yin J
J Neuroimmunol; 2014 Apr; 269(1-2):62-7. PubMed ID: 24582827
[TBL] [Abstract][Full Text] [Related]
38. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
Kim SH; Kwak K; Jeong IH; Hyun JW; Jo HJ; Joung A; Yu ES; Kim JH; Lee SH; Yun S; Joo J; Lee DK; Lee JM; Kim HJ
Mult Scler; 2016 Dec; 22(14):1850-1858. PubMed ID: 26920380
[TBL] [Abstract][Full Text] [Related]
39. Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast.
Roberts DR; Holden KR
Brain Dev; 2016 Mar; 38(3):331-6. PubMed ID: 26345358
[TBL] [Abstract][Full Text] [Related]
40. Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.
Masuda H; Mori M; Uzawa A; Uchida T; Ohtani R; Kuwabara S
PLoS One; 2020; 15(4):e0224419. PubMed ID: 32251416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
